INTERMUNE PHARMACEUTICALS INC
10-Q/A, EX-27, 2000-10-30
PHARMACEUTICAL PREPARATIONS
Previous: INTERMUNE PHARMACEUTICALS INC, 10-Q/A, 2000-10-30
Next: INTERMUNE PHARMACEUTICALS INC, 10-Q, 2000-10-30



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from financial
statements for the six-month period ending June 30, 2000 and is qualified in its
entirety to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<EXCHANGE-RATE>                                   1.00
<CASH>                                         127,740
<SECURITIES>                                         0
<RECEIVABLES>                                    1,729
<ALLOWANCES>                                     (175)
<INVENTORY>                                        357
<CURRENT-ASSETS>                               133,517
<PP&E>                                             721
<DEPRECIATION>                                    (39)
<TOTAL-ASSETS>                                 134,449
<CURRENT-LIABILITIES>                            2,544
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            22
<OTHER-SE>                                     131,883
<TOTAL-LIABILITY-AND-EQUITY>                   134,449
<SALES>                                          3,133
<TOTAL-REVENUES>                                 3,133
<CGS>                                          (3,160)
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                              (15,065)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               (134)
<INCOME-PRETAX>                               (12,531)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (12,531)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (12,531)
<EPS-BASIC>                                     (3.42)
<EPS-DILUTED>                                   (3.42)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission